Maryland Capital Advisors’s Zimmer Biomet ZBH Stock Holding History

Maryland Capital Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.53K	Buy	+41	New	+$3.6K	﹤0.01%	229
2025 Q4	$3.6K	Hold	40	–	–	﹤0.01%	232
2025 Q3	$3.94K	Hold	40	–	–	﹤0.01%	211
2025 Q2	$3.65K	Hold	40	–	–	﹤0.01%	229
2025 Q1	$4.53K	Hold	40	–	–	﹤0.01%	188
2024 Q4	$4.23K	Hold	40	–	–	﹤0.01%	212
2024 Q3	$4.32K	Hold	40	–	–	﹤0.01%	208
2024 Q2	$4.34K	Hold	40	–	–	﹤0.01%	208
2024 Q1	$5.28K	Hold	40	–	–	﹤0.01%	182
2023 Q4	$4.87K	Hold	40	–	–	﹤0.01%	188
2023 Q3	$4.49K	Hold	40	–	–	﹤0.01%	188
2023 Q2	$5.82K	Buy	+40	New	+$5.44K	﹤0.01%	187

Other funds holding ZBH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

EIC

Equity Investment Corp Atlanta, Georgia $5.24B AUM 11.32% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.65B AUM 26.74% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Maryland Capital Advisors's ZBH Position: Q2 2026 in Review

Maryland Capital Advisors opened a new position in Zimmer Biomet (ZBH) in Q2 2026: 41 shares worth $3.53K. The stake represents ﹤0.01% of the portfolio and ranks #229 among its holdings. This is a return to the name: Maryland Capital Advisors previously reported a position in ZBH as recently as Q4 2025.

Maryland Capital Advisors first reported a position in ZBH in Q2 2023 and has held it in 12 quarters since. The position peaked at $5.82K in Q2 2023. 489 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Maryland Capital Advisors held 41 shares of Zimmer Biomet worth $3.53K as of Q2 2026.
Zimmer Biomet was a new Maryland Capital Advisors position in Q2 2026.
Zimmer Biomet made up ﹤0.01% of Maryland Capital Advisors's portfolio in Q2 2026, its #229 holding.
Maryland Capital Advisors first reported a position in Zimmer Biomet in Q2 2023 and has held it in 12 quarters since.
Maryland Capital Advisors's Zimmer Biomet position peaked at $5.82K in Q2 2023.
489 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Maryland Capital Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.